Peetz Christopher's Form 4/A amendment
AmendedAlpine Immune Sciences, Inc. (ALPN) · filed Sep 27, 2021
- Accession no.
- 0001626199-21-000131
- Filed
- Sep 27, 2021
- Trade date
- Sep 23, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 24, 2021
This filing lists 1 non-derivative transaction. Open-market purchases total $19.3K. It was filed 4 days after the trade.
This amendment replaces 0001626199-21-000126 (filed Sep 24, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peetz ChristopherCIK 0001614740 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Common Stock | PPurchaseAcquired | +1,900 | $10.17 | +$19,323 | 1,900 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Form 4 filed on September 24, 2021 inadvertently included an incorrect transaction code for the reported transaction. The transaction code included on the original Form 4 was "S" while the correct transaction code should have been "P".